首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1524242

勃起功能障礙設備市場- 按設備類型（非手術設備、手術設備）、按年齡層（<40、40 -60 歲、>60）、按原因（糖尿病、神經系統疾病、高血壓）、依最終用途（醫院、診所、ASC）及預測，2024 - 2032 年

Erectile Dysfunction Device Market - By Device Type (Non-Surgical Devices, Surgical Devices), By Age Group (<40, 40 -60 years, >60), By Cause (Diabetes, Neurological disorders, Hypertension), By End-use (Hospitals, Clinics, ASCs) & Forecast, 2024 - 2032

出版日期: 2024年04月24日 | 出版商:

Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在全球倡導團體和醫療保健提供者不斷加強消除勃起功能障礙的推動下，全球勃起功能障礙設備市場在 2024 年至 2032 年間複合年成長率將超過 9.3%。透過挑戰社會禁忌和促進公開對話，這些措施使男性能夠毫無恐懼或羞恥地尋求必要的醫療援助。這種文化轉變可以改善個人健康狀況，並推動勃起功能障礙治療市場的成長。

例如，2023 年 11 月，MangoRx 發起了一項關注男性健康意識的慈善活動。該公司承諾將整個月捐贈其品牌商品銷售收入的 50%，以支持各種男性健康和保健慈善機構。

隨著越來越多的男性願意討論自己的擔憂並獲得醫療保健服務，對有效解決方案（包括醫療設備和療法）的需求也在增加。最終，消除污名化的努力在擴大勃起功能障礙治療市場、加強整體患者護理方面發揮著至關重要的作用。

整個勃起功能障礙設備市場根據設備類型、年齡層、原因、最終用途和地區進行分類。

從2024 年到2032 年，手術器械領域的複合年成長率將令人印象深刻。。此外，手術技術和設備設計的進步改善了結果，減少了併發症並縮短了恢復時間。隨著人們認知的提高和對 ED 的恥辱感的減少，越來越多的男性正在探索手術選擇作為恢復性功能的可行解決方案。這一趨勢得到了為患者尋求有效、持久治療選擇的醫療保健提供者的支持。

由於多發性硬化症和脊髓損傷 SCI 等可導致 ED 的疾病普遍存在，到 2032 年，神經系統疾病領域將佔據顯著的勃起功能障礙設備市場佔有率。這些患者通常需要專門的治療，以解決影響性功能的神經方面以及實現和維持勃起的身體能力。 ED 設備提供了非侵入性或微創選項，可以整合到綜合治療計劃中，為這些患者提供恢復性功能並改善生活品質的機會，儘管他們有潛在的神經系統疾病。

歐洲勃起功能障礙設備市場將顯著成長，到2032 年複合年成長率有望實現。有效解決方案的需求。許多歐洲國家醫療保健基礎設施和報銷政策的創新使這些設備更容易被更廣泛的人使用。對醫療保健和生活品質的文化態度也有所貢獻，因為越來越多的男性尋求能夠謹慎有效地恢復性功能的非侵入性治療，從而促進市場成長。

產業生態系統分析
產業影響力
- 成長動力
  - 勃起功能障礙的盛行率不斷增加
  - 設備技術進步
  - 意識和接受度不斷提高
  - 研發投入增加
- 產業陷阱與挑戰
  - 併發症的風險
成長潛力分析
監管環境
技術景觀
報銷場景
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板

第 5 章：市場估計與預測：按設備類型，2021 - 2032 年

主要趨勢
非手術器械
- 勃起功能障礙衝擊波發生器
- 真空收縮裝置
- 外部陰莖剛性裝置
手術器械
- 陰莖植入物
  - 充氣植入物
  - 可延展植入物
- 其他手術器械

第 6 章：市場估計與預測：按年齡分類，2021 - 2032

主要趨勢
少於 40
40-60歲
超過60年

第 7 章：市場估計與預測：按原因分類，2021 年 - 2032 年

主要趨勢
糖尿病
神經系統疾病
高血壓
其他原因

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
診所
門診手術中心
其他最終用戶

第 9 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

Augusta Medical Systems
Boston Scientific Corporation
Coloplast Corporation
Medispec Ltd.
MTS Medical UG
NOVAmedtek
Owen Mumford Ltd.
Promedon
SILIMED
STORZ MEDICAL AG
Zephyr Surgical Implants
Zimmer Aesthetics

簡介目錄

Product Code: 9193

Global Erectile Dysfunction Device Market will indicate over 9.3% CAGR between 2024 and 2032, driven by escalating efforts to destigmatize erectile dysfunction by advocacy groups and healthcare providers globally. By challenging societal taboos and promoting open dialogue, these initiatives empower men to seek necessary medical assistance without fear or shame. This cultural shift enhances individual health outcomes and fuels market growth for erectile dysfunction treatments.

For instance, in November 2023, MangoRx launched a charitable campaign focusing on mens health awareness. The company pledges to donate 50% of sales proceeds from its branded merchandise throughout the month to support various mens health and wellness charities.

As more men feel comfortable discussing their concerns and accessing healthcare services, demand rises for effective solutions, including medical devices and therapies. Ultimately, destigmatization efforts play a crucial role in expanding the market for erectile dysfunction treatments, enhancing overall patient care.

The overall erectile dysfunction device market is classified based on device type, age group, cause, end-use, and region.

The surgical devices segment will register an impressive CAGR from 2024 to 2032. Surgical devices, such as penile implants, offer a long-term solution for ED that may be preferred by patients who have not responded well to other treatments. Moreover, advancements in surgical techniques and device design have improved outcomes, reducing complications and recovery times. As awareness grows and the stigma surrounding ED diminishes, more men are exploring surgical options as a viable solution to restore sexual function. This trend is supported by healthcare providers seeking effective, durable treatment options for their patients.

The neurological disorders sector will seize a notable erectile dysfunction device market share by 2032 because of the prevalence of conditions such as multiple sclerosis MS and spinal cord injuries SCI that can lead to ED. These patients often require specialized treatments that can address both the neurological aspects affecting sexual function and the physical ability to achieve and maintain an erection. ED devices provide non-invasive or minimally invasive options that can be integrated into comprehensive treatment plans, offering these patients a chance to regain sexual function and improve their quality of life despite their underlying neurological conditions.

Europe erectile dysfunction device market will register significant growth, with a promising CAGR through 2032. Europe aging population, coupled with increasing awareness and acceptance of ED as a treatable condition, has fueled demand for effective solutions like ED devices. Innovations in healthcare infrastructure and reimbursement policies in many European countries have made these devices more accessible to a broader demographic. Cultural attitudes toward healthcare and quality of life also contribute, as more men seek out non-invasive treatments that can restore sexual function discreetly and effectively, bolstering market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of erectile dysfunction
  - 3.2.1.2 Technological advancement in devices
  - 3.2.1.3 Growing awareness and acceptance
  - 3.2.1.4 Rise in R&D investment
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Risk of complications
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Reimbursement scenario
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Device Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Non-surgical devices
- 5.2.1 Erectile dysfunction shock wave generators
- 5.2.2 Vacuum constriction devices
- 5.2.3 External penile rigidity devices
5.3 Surgical devices
- 5.3.1 Penile implants
  - 5.3.1.1 Inflatable implants
  - 5.3.1.2 Malleable implants
- 5.3.2 Other surgical devices

Chapter 6 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Less than 40
6.3. 40-60 years
6.4 More than 60 years

Chapter 7 Market Estimates and Forecast, By Cause, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Diabetes
7.3 Neurological disorders
7.4 Hypertension
7.5 Other causes

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Clinics
8.4 Ambulatory surgical centers
8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa